{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:06:56Z","timestamp":1791025616948,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.critrevonc.2013.07.015","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T16:13:16Z","timestamp":1376583196000},"page":"625-636","source":"Crossref","is-referenced-by-count":98,"title":["Clinical evaluation and optimal management of cancer cachexia"],"prefix":"10.1016","volume":"88","author":[{"given":"Albert","family":"Tuca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Jimenez-Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Gasc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.critrevonc.2013.07.015_bib0005","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.critrevonc.2010.10.004","article-title":"Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer","volume":"80","author":"Blum","year":"2011","journal-title":"Critical Reviews Oncology\/Hematology"},{"issue":"12","key":"10.1016\/j.critrevonc.2013.07.015_bib0010","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.medcli.2010.06.003","article-title":"Cancer cachexia","volume":"135","author":"Tuca Rodr\u00edguez","year":"2010","journal-title":"Medicina Clinica"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.07.015_bib0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.critrevonc.2012.02.001","article-title":"Clinical nutrition, body composition and oncology: a critical literature review of the synergies","volume":"84","author":"Jacquelin-Ravel","year":"2012","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"6","key":"10.1016\/j.critrevonc.2013.07.015_bib0020","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clinical Nutrition"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.07.015_bib0025","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.clnu.2012.06.012","article-title":"The 2011 ESPEN Arvid Wretlind lecture: cancer cachexia: the potential impact of translational research on patient-focused outcomes","volume":"31","author":"Fearon KC","year":"2012","journal-title":"Clinical Nutrition"},{"issue":"8","key":"10.1016\/j.critrevonc.2013.07.015_bib0030","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa1000678","article-title":"Early palliative care for patients with metastatic non-small-cell lung cancer","volume":"363","author":"Temel","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.07.015_bib0035","doi-asserted-by":"crossref","first-page":"1123S","DOI":"10.3945\/ajcn.2010.28608A","article-title":"Skeletal muscle loss: cachexia, sarcopenia, and inactivity","volume":"91","author":"Evans","year":"2010","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1016\/j.critrevonc.2013.07.015_bib0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2147\/CMAR.S7101","article-title":"Optimal management of cancer anorexia\u2013caquexia syndrome","volume":"2","author":"Argil\u00e9s","year":"2010","journal-title":"Cancer Management and Research"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.07.015_bib0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metabolism"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.07.015_bib0050","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncology"},{"issue":"10","key":"10.1016\/j.critrevonc.2013.07.015_bib0055","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s00520-003-0486-0","article-title":"Evaluation of nutritional status in advanced metastatic cancer","volume":"11","author":"Sarhill","year":"2003","journal-title":"Supportive Care in Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.07.015_bib0060","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.clnu.2005.05.001","article-title":"An epidemiological evaluation of the prevalence of malnutrition in Spanish patients with locally advanced or metastatic cancer","volume":"24","author":"Segura","year":"2005","journal-title":"Clinical Nutrition"},{"key":"10.1016\/j.critrevonc.2013.07.015_bib0065","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S1470-2045(00)00033-4","article-title":"Cachexia and asthenia in cancer patients","volume":"1","author":"Bruera","year":"2000","journal-title":"Lancet Oncology"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.07.015_bib0070","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative OncologyGroup","volume":"69","author":"Dewys","year":"1980","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.critrevonc.2013.07.015_bib0075","first-page":"4","article-title":"Fisiopatolog\u00eda de la caquexia neopl\u00e1sica","volume":"21","author":"Argil\u00e9s","year":"2006","journal-title":"Nutrici\u00f3n hospitalaria"},{"issue":"3-4","key":"10.1016\/j.critrevonc.2013.07.015_bib0080","first-page":"173","article-title":"Clinical impact of cachexia on survival and outcome of cancer patients","volume":"43","author":"Dimitriu","year":"2005","journal-title":"Romanian Journal of Internal Medicine"},{"issue":"7","key":"10.1016\/j.critrevonc.2013.07.015_bib0085","doi-asserted-by":"crossref","first-page":"322","DOI":"10.12968\/ijpn.2009.15.7.43421","article-title":"A difficult clinical problem: diagnosis, impact and clinical management of cachexia in palliative care","volume":"15","author":"Holmes","year":"2009","journal-title":"International Journal of Palliative Nursing"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.07.015_bib0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/SPC.0b013e3283311d09","article-title":"Mechanisms and treatment of cancer cachexia","volume":"3","author":"Argil\u00e9s","year":"2009","journal-title":"Current Opinion in Supportive and Palliative Care"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.07.015_bib0095","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1615\/CritRevOncog.v17.i3.30","article-title":"Counteracting inflammation: a promising therapy in cachexia","volume":"17","author":"Argiles","year":"2012","journal-title":"Critical Reviews in Oncogenesis"},{"key":"10.1016\/j.critrevonc.2013.07.015_bib0100","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S1359-6446(03)02826-5","article-title":"Catabolic mediators as targets for cancer cachexia","volume":"8","author":"Argil\u00e9s","year":"2003","journal-title":"Drug Discovery Today"},{"issue":"6","key":"10.1016\/j.critrevonc.2013.07.015_bib0105","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1079\/BJN20041292","article-title":"Bioelectrical impedance phase angle as a prognostic indicator in advanced pancreatic cancer","volume":"92","author":"Gupta","year":"2004","journal-title":"British Journal of Nutrition"},{"issue":"6","key":"10.1016\/j.critrevonc.2013.07.015_bib0110","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/ajcn\/80.6.1634","article-title":"Bioelectrical impedance phase angle in clinical practice: implications for prognosis in advanced colorectal cancer","volume":"80","author":"Gupta","year":"2004","journal-title":"American Journal of Clinical Nutrition"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.07.015_bib0115","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/1049909108330028","article-title":"Bioelectrical impedance phase angle changes during hydration and prognosis in advanced cancer","volume":"26","author":"Davis","year":"2009","journal-title":"American Journal of Hospice and Palliative Care"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.07.015_bib0120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00520-009-0798-9","article-title":"Standardized phase angle from bioelectrical impedance analysis as prognostic factor for survival in patients with cancer","volume":"19","author":"Paiva","year":"2010","journal-title":"Supportive Care in Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2013.07.015_bib0125","first-page":"953","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population based study","volume":"26","author":"Prado","year":"2002","journal-title":"Lancet Oncology"},{"issue":"8","key":"10.1016\/j.critrevonc.2013.07.015_bib0130","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","article-title":"Sarcopenia as a determinant of chemotherapy toxicity and time tumor progression in metastatic breast cancer patients receiving capecitabine treatment","volume":"15","author":"Prado","year":"2009","journal-title":"Clinical Cancer Research"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.07.015_bib0135","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1097\/01.NCC.0000290818.45066.00","article-title":"Critical evaluation of nutrition screening tools recommended for oncology patients","volume":"30","author":"Kubrak","year":"2007","journal-title":"Cancer Nursing"},{"issue":"11","key":"10.1016\/j.critrevonc.2013.07.015_bib0140","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s00520-006-0070-5","article-title":"Validity of the malnutrition screening tool as an effective predictor of nutritional risk in oncology outpatients receiving chemotherapy","volume":"14","author":"Isenring","year":"2006","journal-title":"Supportive Care in Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.07.015_bib0145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/014860718701100108","article-title":"What is subjective global assessment of nutritional status?","volume":"11","author":"Detsky","year":"1987","journal-title":"Journal of Parenteral and Enteral Nutrition"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.07.015_bib0150","first-page":"9","article-title":"Oncology patient-generated SGA of nutritional status","volume":"1","author":"Ottery","year":"1994","journal-title":"Nutrition Oncology"},{"issue":"16","key":"10.1016\/j.critrevonc.2013.07.015_bib0155","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJM198204223061606","article-title":"Nutritional assessment: a comparison of clinical judgement and objective measures","volume":"306","author":"Baker","year":"1982","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.critrevonc.2013.07.015_bib0160","first-page":"353","article-title":"Valoraci\u00f3n subjetiva global en el paciente neopl\u00e1sico desarrollada por servicios de nutrici\u00f3n vs oncolog\u00eda. \u00bfEs siempre \u00fatil evaluar el estado nutricional?","volume":"18","author":"G\u00f3mez-Candela","year":"2003","journal-title":"Nutricion Hospitalaria"},{"issue":"10","key":"10.1016\/j.critrevonc.2013.07.015_bib0165","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1023\/A:1016670403148","article-title":"Revalidation and shortening of the functional assessment anorexia\/caquexia therapy (FAACT) questionnaire","volume":"9","author":"Ribaudo","year":"2001","journal-title":"Quality of Life Research"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.07.015_bib0170","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The functional assessment of cancer therapy scale: development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.07.015_bib0175","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/0148607108325076","article-title":"Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group","volume":"33","author":"Bozzetti","year":"2009","journal-title":"Journal of Parenteral and Enteral Nutrition"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.07.015_bib0180","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00520-009-0800-6","article-title":"Evolving classification systems in cancer cachexia: ready for clinical practice?","volume":"18","author":"Blum","year":"2010","journal-title":"Supportive Care in Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.07.015_bib0185","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1188\/09.ONF.439-445","article-title":"Fighting over food: patient and family understanding of cancer cachexia","volume":"36","author":"Reid","year":"2009","journal-title":"Oncology Nursing Forum"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.07.015_bib0190","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/0269216307076346","article-title":"Fighting a losing battle: eating related distress of men with advanced cancer and their females partners. A mixed-methods study","volume":"21","author":"Strasser","year":"2007","journal-title":"Palliative Medicine"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.07.015_bib0195","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1191\/0269216305pm1001oa","article-title":"Symptom distress as rated by advanced cancer patients, caregivers and physicians in the last week of life","volume":"19","author":"Oi-Ling","year":"2005","journal-title":"Palliative Medicine"},{"key":"10.1016\/j.critrevonc.2013.07.015_bib0200","series-title":"Free oral communication presented at: Congreso de la Sociedad Espa\u00f1ola de Cuidados Paliativos [Congress of Spanish Palliative Care Society]","article-title":"Alteraci\u00f3n de la imagen corporal en los pacientes con c\u00e1ncer avanzado: estudio descriptivo, prospectivo, multic\u00e9ntrico","author":"Codorniu","year":"2010"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.07.015_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00520-009-0722-3","article-title":"Cancer caquexia: medical management","volume":"18","author":"Mantovani","year":"2010","journal-title":"Supportive Care in Cancer"},{"issue":"13","key":"10.1016\/j.critrevonc.2013.07.015_bib0210","doi-asserted-by":"crossref","first-page":"1.127","DOI":"10.1093\/jnci\/82.13.1127","article-title":"Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia","volume":"82","author":"Loprinzi","year":"1990","journal-title":"Journal of the National Cancer Institute"},{"issue":"6 Suppl. 9","key":"10.1016\/j.critrevonc.2013.07.015_bib0215","first-page":"8","article-title":"Alleviation of cancer anorexia and cachexia: studies of the Mayo Clinic and the North Central Cancer Treatment Group","volume":"17","author":"Loprinzi","year":"1990","journal-title":"Seminars in Oncology"},{"issue":"6","key":"10.1016\/j.critrevonc.2013.07.015_bib0220","doi-asserted-by":"crossref","DOI":"10.1002\/1097-0142(19900915)66:6<1279::AID-CNCR2820660630>3.0.CO;2-R","article-title":"A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer","volume":"66","author":"Bruera","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2013.07.015_bib0225","unstructured":"http:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/index.cfm?fuseaction=Search.DrugDetails (accessed 09.11.12)."},{"issue":"5","key":"10.1016\/j.critrevonc.2013.07.015_bib0230","first-page":"255","article-title":"Megestrol in the treatment of AIDS associated cachexia. Evaluation by bioelectric impedance analysis of body composition","volume":"15","author":"P\u00e9rez De Oteyza","year":"1998","journal-title":"Anales de Medicina Interna"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.07.015_bib0235","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1532-5415.2000.tb04993.x","article-title":"Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study","volume":"48","author":"Yeh","year":"2000","journal-title":"Journal of the American Geriatrics Society"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.07.015_bib0240","doi-asserted-by":"crossref","first-page":"M48","DOI":"10.1093\/gerona\/56.1.M48","article-title":"The correlation of cytokine levels with body weight after megestrol acetate treatment in geriatric patients","volume":"56","author":"Yeh","year":"2001","journal-title":"Journals of Gerontology. Series A, Biological Sciences and Medical Sciences"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.07.015_bib0245","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0885-3924(94)90104-X","article-title":"Management of anorexic patients in radiotherapy: a prospective randomized comparison of megestrol and prednisolone","volume":"9","author":"Lai","year":"1994","journal-title":"Journal of Pain and Symptom Management"},{"issue":"10","key":"10.1016\/j.critrevonc.2013.07.015_bib0250","doi-asserted-by":"crossref","first-page":"3.299","DOI":"10.1200\/JCO.1999.17.10.3299","article-title":"Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia\/cachexia","volume":"17","author":"Loprinzi","year":"1999","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.07.015_bib0255","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1200\/JCO.20.2.567","article-title":"Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group Study","volume":"20","author":"Jatoi","year":"2002","journal-title":"Journal of Clinical Oncology"},{"issue":"12","key":"10.1016\/j.critrevonc.2013.07.015_bib0260","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1200\/JCO.2004.06.024","article-title":"An eicosapentaenoic acid supplement versus megestrol acetate versus both per patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada Collaborative Effort","volume":"22","author":"Jatoi","year":"2004","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.07.015_bib0265","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0167-8140(97)01921-X","article-title":"Effect of megestrol acetate and prepulsid on nutritional improvement in patients with head and neck cancers undergoing radiotherapy","volume":"43","author":"Chen","year":"1997","journal-title":"Radiotherapy and Oncology"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.07.015_bib0270","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/gye.15.5.341.348","article-title":"Hemostatic effects of high-dose megestrol acetate therapy in patients with advanced gynecological cancer","volume":"15","author":"Oberhoff","year":"2001","journal-title":"Gynecological Endocrinology"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.07.015_bib0275","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jpainsymman.2003.09.007","article-title":"Systematic review of megestrol acetate in the treatment of anorexia\u2013cachexia syndrome","volume":"27","author":"Pascual L\u00f3pez","year":"2004","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1016\/j.critrevonc.2013.07.015_bib0280","series-title":"La Biblioteca Cochrane Plus, n\u00b0. 4","article-title":"Acetato de megestrol para el tratamiento del s\u00edndrome anorexia\u2013caquexia (Revisi\u00f3n Cochrane traducida)","author":"Berenstein","year":"2008"},{"issue":"11","key":"10.1016\/j.critrevonc.2013.07.015_bib0285","first-page":"636","article-title":"Effects of megestrol acetate in patients with cancer anorexia\u2013cachexia syndrome \u2013 a systematic review and meta-analysis","volume":"118","author":"Lesniak","year":"2008","journal-title":"Polskie Archiwum Medycyny Wewnetrznej"},{"issue":"8","key":"10.1016\/j.critrevonc.2013.07.015_bib0290","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1517\/14656560902960162","article-title":"Medroxyprogesterone acetate in the management of cancer cachexia","volume":"10","author":"Maddedu","year":"2009","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.07.015_bib0295","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/082585979401000105","article-title":"A phase II study of delta-9-tetrahydro-cannabinol for appetite stimulation in cancer-associated anorexia","volume":"10","author":"Nelson","year":"1994","journal-title":"Journal of Palliative Care"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.07.015_bib0300","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00520-002-0387-7","article-title":"Established and potential therapeutic applications of cannabinoids in oncology","volume":"11","author":"Walsh","year":"2003","journal-title":"Supportive Care in Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.07.015_bib0305","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00520-002-0431-7","article-title":"Cannabinoids in supportive care: are they necessary?","volume":"11","author":"Bruera","year":"2003","journal-title":"Supportive Care in Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.07.015_bib0310","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1200\/JCO.2003.01.101","article-title":"Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia\/cachexia: a double blind, placebo and controlled study","volume":"21","author":"Bruera","year":"2003","journal-title":"Journal of Clinical Oncology"},{"issue":"21","key":"10.1016\/j.critrevonc.2013.07.015_bib0315","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1200\/JCO.2005.04.5724","article-title":"Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia","volume":"24","author":"Fearon","year":"2006","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.07.015_bib0320","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.nut.2004.05.026","article-title":"Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: a randomized pilot study","volume":"21","author":"Persson","year":"2005","journal-title":"Nutrition"},{"key":"10.1016\/j.critrevonc.2013.07.015_bib0325","first-page":"CD004597","article-title":"Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia","author":"Dewey","year":"2007","journal-title":"Cochrane Database Systematic Review"},{"issue":"6","key":"10.1016\/j.critrevonc.2013.07.015_bib0330","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jpainsymman.2008.06.005","article-title":"Anorexia\u2013cachexia syndrome: a systematic review of the role of dietary polyunsaturated taffy acids in the management of symptoms, survival, and quality of life","volume":"37","author":"Mazzotta","year":"2008","journal-title":"Journal of Pain and Symptom Management"},{"issue":"12","key":"10.1016\/j.critrevonc.2013.07.015_bib0335","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1002\/1097-0142(19900615)65:12<2657::AID-CNCR2820651210>3.0.CO;2-S","article-title":"A controlled trial of cyproheptadine in cancer patients with anorexia and\/or cachexia","volume":"65","author":"Kardinal","year":"1990","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2013.07.015_bib0340","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/MPH.0b013e3181864a5e","article-title":"The effect of cyproheptadine hydrochloride (periactin) and megestrol acetate (megace) on weight in children with cancer\/treatment-related cachexia","volume":"30","author":"Couluris","year":"2008","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.07.015_bib0345","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/hed.20662","article-title":"Results of a pilot study of the effects of celecoxib on cancer cachexia in patients with cancer of the head, neck, and gastrointestinal track","volume":"30","author":"Lai","year":"2008","journal-title":"Head and Neck"},{"issue":"3-4","key":"10.1016\/j.critrevonc.2013.07.015_bib0350","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/sj.bjc.6690077","article-title":"Prospective study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss","volume":"79","author":"McMillan","year":"1999","journal-title":"British Journal of Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2013.07.015_bib0355","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1200\/JCO.1995.13.11.2856","article-title":"Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized double blind placebo trial","volume":"13","author":"Goldberg","year":"1995","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.07.015_bib0360","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/00003495-200060020-00003","article-title":"Potential novel uses of thalidomide: focus on palliative care","volume":"60","author":"Peuckmann","year":"2000","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.critrevonc.2013.07.015_bib0365","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1023\/A:1008329821941","article-title":"Thalidomide in patients with cachexia due to terminal cancer: preliminary report","volume":"10","author":"Bruera","year":"1999","journal-title":"Annals of Oncology"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.07.015_bib0370","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/gut.2004.047563","article-title":"Thalidomide in the treatment of cancer cachexia: a randomized placebo controlled trial","volume":"54","author":"Gordon","year":"2005","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.critrevonc.2013.07.015_bib0375","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1200\/JCO.2012.43.6766","article-title":"Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial","volume":"31","author":"Del Fabbro","year":"2013","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.07.015_bib0380","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s005200100281","article-title":"Is there a role for melatonin in supportive care?","volume":"10","author":"Lissoni","year":"2002","journal-title":"Supportive Care in Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2013.07.015_bib0385","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.clinthera.2007.11.004","article-title":"Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment","volume":"29","author":"Gelato","year":"2007","journal-title":"Clinical Therapeutics"},{"issue":"6","key":"10.1016\/j.critrevonc.2013.07.015_bib0390","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1210\/jc.2003-031768","article-title":"Ghrelin increases energy intake in cancer patients with impaired appetite: acute randomized placebo controlled trial","volume":"89","author":"Neary","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"18S","key":"10.1016\/j.critrevonc.2013.07.015_bib0395","article-title":"A phase II randomized, placebo-controlled, double-blind study of the efficacy and safety of RC-1291 (RC) for the treatment of cancer cachexia","volume":"25","author":"Garc\u00eda","year":"2007","journal-title":"Journal of Clinical Oncology. ASCO Annual Meeting Proceedings"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.07.015_bib0400","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1200\/JCO.1990.8.1.9","article-title":"Hydrazine sulfate influence on nutritional status and survival in non-small-cell lung cancer","volume":"8","author":"Chlebowski","year":"1990","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1016\/j.critrevonc.2013.07.015_bib0405","doi-asserted-by":"crossref","first-page":"1.113","DOI":"10.1200\/JCO.1994.12.6.1113","article-title":"Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B","volume":"12","author":"Kosty","year":"1994","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1016\/j.critrevonc.2013.07.015_bib0410","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jnutbio.2004.02.002","article-title":"Fish oil supplementation in F1 generation associated with naproxen, clenbuterol, and insulin administration reduce tumor growth and cachexia in Walker 256 tumor-bearing rats","volume":"15","author":"Pinto","year":"2004","journal-title":"Journal of Nutritional Biochemistry"},{"issue":"6","key":"10.1016\/j.critrevonc.2013.07.015_bib0415","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00520-005-0787-6","article-title":"Is bortezomib, a proteasome inhibitor, effective in treating cancer-associated weight loss? Preliminary results from the North Central Cancer Treatment Group","volume":"13","author":"Jatoi","year":"2005","journal-title":"Supportive Care in Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.07.015_bib0420","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1634\/theoncologist.2009-0153","article-title":"Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia","volume":"15","author":"Mantovani","year":"2010","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.07.015_bib0425","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.nut.2007.12.010","article-title":"Randomized phase III clinical trial of five different arms of treatment for patients with advanced cancer: interim results","volume":"24","author":"Mantovani","year":"2008","journal-title":"Nutrition"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842813001662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842813001662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T00:37:55Z","timestamp":1596328675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842813001662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1040842813001662"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2013.07.015","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}